Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketotifen/vasoconstrictor in Allergic Conjunctivitis
NCT00375596Phase 2Withdrawn
- Sponsor
- Bausch + Lomb
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ketotifen in allergic conjunctivitis (AC), sponsored by Bausch + Lomb. Status: withdrawn.
02
Drugs
ketotifen
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT00375596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00375596.